Predict your next investment

HEALTHCARE | Biotechnology
igeneon.com

See what CB Insights has to offer

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$68.9M

About Igeneon

Developer of cancer vaccines against major cancer types such as colorectal, gastric, and prostate cancer. The cancer vaccines are meant to stimulate the immune system selectively as to help a patient's own systems to react against cancer cells. The vaccines are designed to prevent metastases, thus prolonging survival time. The company also aims for its products to be used in other preventative applications.[Keywords: immunotherapy]

Igeneon Headquarter Location

Brunner Strasse 69/3

Vienna, 1230,

Austria

43 1 902 50 130

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.